Researchers examined real-world characteristics of patients receiving albuterol multidose dry powder inhaler or short-acting β2 agonists with short-acting β2 agonists. More patients using albuterol ...

The US Food and Drug Administration (FDA) has approved the short-acting beta-agonist (SABA) albuterol sulfate inhalation powder (ProAir RespiClick, Teva) for the treatment or prevention of ...

What type of asthma inhaler is right for you? In the U.S., 25 million people are affected by asthma. That’s roughly 1 in 13 adults and children. Asthma can be mild or severe. Some people with asthma ...

Despite effective pharmacological options for treating asthma, most patients fail to achieve good control. 1 Non-adherence is common, with over-reliance on short-acting P2-agonists (SABA) and ...

Please provide your email address to receive an email when new articles are posted on . Rates of overprescribing of short-acting beta agonist asthma inhalers remain high and vary significantly among ...

Not just weight: Even kids who aren’t obese can develop a severe, non-allergic form of asthma due to consumption of specific dietary fats. Stearic vs. oleic: Saturated stearic acid ramps up lung ...

Collaboration combines Teva’s expertise in respiratory technology development and Launch Therapeutics’ innovative late-stage drug development model to progress Teva’s Dual-Action Asthma Rescue Inhaler ...

Overuse of these inhalers is linked to an increased risk of hospital admissions and severe asthma attacks. They also found that prescribing varies between GP practices, with some overprescribing ...

Asthma is a chronic lung condition characterized by inflammation and narrowness in the airways that carry air in and out of the lungs. About 1 in 13 people in the United States are affected by asthma.

In the U.S., 25 million people are affected by asthma. That’s roughly 1 in 13 adults and children. Asthma can be mild or severe. Some people with asthma have symptoms every day. Others have symptoms ...